Literature DB >> 24802610

Cell therapy for bone repair: narrowing the gap between vision and practice.

J P Stegemann1, S Verrier, F Gebhard, M W Laschke, I Martin, H Simpson, T Miclau.   

Abstract

This position paper summarises a vision of how cell-based therapies can be applied clinically to regenerate bone, as well as the steps needed to narrow the gap between that vision and clinical reality. It is a result of the presentations and discussion of the "Cell Therapy for Bone Repair" breakout session at the AO Foundation Symposium "Where Science Meets Clinics" in Davos, Switzerland from September 5-7, 2013. Participants included leaders from science, medicine, and industry from around the world. The session included clinical and scientific presentations, as well as an extended discussion among participants. Bone tissue has an innate regenerative capacity that in most cases allows functional healing at damage sites. However, there are a number of serious conditions in which bone does not fully heal and the result is significant morbidity. The clinical need for new therapies is clear, and the breakout session participants were enthusiastic about the potential impact on cell-based therapies for bone repair in the clinic. However, they also recognised the significant challenges that face the development of commercially viable cell therapy products. This paper outlines a vision in which patient selection is based on expected therapeutic outcome to create a consistently successful, cost-effective, cell-based therapy for bone repair. The need for a more complete understanding of bone repair, a better infrastructure for preclinical studies, and the need for collaboration among stakeholders is discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24802610      PMCID: PMC4076936          DOI: 10.22203/ecm.v027sa01

Source DB:  PubMed          Journal:  Eur Cell Mater        ISSN: 1473-2262            Impact factor:   3.942


  7 in total

1.  Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells.

Authors:  Dewei Zhao; Daping Cui; Benjie Wang; Fengde Tian; Lin Guo; Lei Yang; Baoyi Liu; Xiaobing Yu
Journal:  Bone       Date:  2011-11-07       Impact factor: 4.398

2.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

Review 3.  In vivo models of bone repair.

Authors:  L A Mills; A H R W Simpson
Journal:  J Bone Joint Surg Br       Date:  2012-07

4.  Clinical application of human mesenchymal stromal cells for bone tissue engineering.

Authors:  Anindita Chatterjea; Gert Meijer; Clemens van Blitterswijk; Jan de Boer
Journal:  Stem Cells Int       Date:  2010-11-11       Impact factor: 5.443

5.  The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.

Authors:  Yaokai Gan; Kerong Dai; Pu Zhang; Tingting Tang; Zhenan Zhu; Jianxi Lu
Journal:  Biomaterials       Date:  2008-07-18       Impact factor: 12.479

6.  A tissue engineering strategy for the treatment of avascular necrosis of the femoral head.

Authors:  A Aarvold; J O Smith; E R Tayton; A M H Jones; J I Dawson; S Lanham; A Briscoe; D G Dunlop; R O C Oreffo
Journal:  Surgeon       Date:  2013-03-27       Impact factor: 2.392

7.  Allograft cellular bone matrix in extreme lateral interbody fusion: preliminary radiographic and clinical outcomes.

Authors:  Antoine G Tohmeh; Blake Watson; Mirna Tohmeh; Xavier J Zielinski
Journal:  ScientificWorldJournal       Date:  2012-12-02
  7 in total
  4 in total

1.  Surveillance of Stem Cell Fate and Function: A System for Assessing Cell Survival and Collagen Expression In Situ.

Authors:  Graham G Walmsley; Kshemendra Senarath-Yapa; Taylor L Wearda; Siddharth Menon; Michael S Hu; Dominik Duscher; Zeshaan N Maan; Jonathan M Tsai; Elizabeth R Zielins; Irving L Weissman; Geoffrey C Gurtner; H Peter Lorenz; Michael T Longaker
Journal:  Tissue Eng Part A       Date:  2015-12-24       Impact factor: 3.845

2.  Defective Bone Repair in C57Bl6 Mice With Acute Systemic Inflammation.

Authors:  D A Behrends; D Hui; C Gao; A Awlia; Y Al-Saran; A Li; J E Henderson; P A Martineau
Journal:  Clin Orthop Relat Res       Date:  2016-11-14       Impact factor: 4.176

3.  Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential.

Authors:  Kaitlin C Murphy; Marissa L Hughbanks; Bernard Y K Binder; Caroline B Vissers; J Kent Leach
Journal:  Ann Biomed Eng       Date:  2014-12-20       Impact factor: 3.934

4.  Synergistic enhancement of ectopic bone formation by supplementation of freshly isolated marrow cells with purified MSC in collagen-chitosan hydrogel microbeads.

Authors:  Joel K Wise; Andrea I Alford; Steven A Goldstein; Jan P Stegemann
Journal:  Connect Tissue Res       Date:  2015-09-04       Impact factor: 3.417

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.